It's World Benzodiazepine Awareness Day! 💊 ​ For the UN Decade of Healthy Ageing, the WHO’s new monitoring framework recognises safe medication use as a cornerstone of ageing well, including indicators for older persons: 🔹Prescribed benzodiazepines for >1 year ​ 🔹Taking 5+ medications daily 1/n

Just ten days left to apply for this Research Fellow position, focused on pharmacoepidemiology and deprescribing. More information about the DIAMOND programme available at: diamond-deprescribing.eu Full job description here (deadline July 7th): my.corehr.com/pls/rcsirecr...

We work on developing methods to better support research on deprescribing and to ultimately improve medicines optimisation. You can find out more about the DIAMOND research programme on our website or LinkedIn profile: diamond-deprescribing.eu www.linkedin.com/company/diamond-derx/

Interested in medications, data and deprescribing? We're looking for a Research Fellow to join the @diamond-derx.bsky.social team @rcsi.bsky.social! If you're an experienced researcher interested in harnessing routine healthcare data, please apply by 7 July: my.corehr.com/pls/rcsirecr...

This new qualitative study showcased that older adults’ readiness for deprescribing is influenced by their medication valuation, decision-making preferences, and openness to change. A combination of these attributes can be used to define 5 distinct patient types. www.annfammed.org/content/23/3...

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

#DePhaRM group and @frankmoriarty.bsky.social were delighted to welcome Dr Justin Turner (@optimisingrxuse.bsky.social) for today’s @rcsi.bsky.social PBS seminar. He gave an inspiring look at Pharmacist-led #deprescribing in real-world care through the SaferMedsNL initiative. #ImplementationScience

At DIAMOND, we care about doing transparency and reproducibility - not just saying it. We recently read @antonpottegaard.bsky.social’s “10 Must-Read Papers on Transparency in Pharmacoepi” and turned recommendations into action. 🧵

DIAMOND WP2 is exploring how simulation can support target trial emulation in deprescribing research. We recently conducted a review of simulation studies - 📢preprint now here: doi.org/10.1101/2025.... We also attended a brilliant simulation course led by Tim Morris, UCL: tinyurl.com/UCLSimTraining

Last few days to apply for this funded PhD on deprescribing in chronic kidney disease, closes on Monday 2nd June!

TOMORROW: Don't miss the next International Deprescribing Journal Club with Dr. Karen Voigt, hosted by the German Deprescribing Network! Register here: us02web.zoom.us/meeting/regi...

Searching for evidence-based literature on the safe and quality use of medications in older adults? 📖 Don't miss the new #Polypharmacy and #Geriatrics book from Nagham Ailabouni, including must-read chapters from global #deprescribing leaders! 🌎 buff.ly/6NXSdxb

Pharmacoepidemiology is at a crossroads 🛣️ Discover how a proposed transparency statement can advance openness and reproducibility in research in our latest guest blog post from @antonpottegaard.bsky.social and @shirleywangv.bsky.social. #Pharmacoepidemiology #Transparency #OpenScience

Join the next Int. Deprescribing Journal Club session on May 23rd!

🚨ICYMI - Updated Cochrane #SystematicReview: Withdrawal of antihypertensive drugs in older people 💊 doi.org/10.1002/1465... "Future research should focus on populations with the greatest uncertainty of the benefit:risk ratio" #CochraneEvidence #bloodpressure #deprescribing

It’s official: we are partnering with @deprescribeus.bsky.social to welcome you in Montréal for the next International Conference on Deprescribing! Mark your calendars for Apr 27-29, 2026! Follow us to stay informed about ICOD2026, including the call for abstracts and registration details.

ICYMI - #Deprescribing webinar recording! 😍 When making decisions about 🛑#statins, consider: ✅pt values, preferences ✅health status ✅current evidence Watch as the TI's Dr. Wade Thompson summarizes current evidence: tiny.cc/StatinDepres...

Great article detailing the life-cycle of medications and all the greenhouse gas (GHG) emissions that are produced along the way: www.cfp.ca/content/71/4... #Deprescribing is one of the easiest and most cost-effective strategies to reduce healthcare emissions! @peachhealthon.bsky.social

The DIAMOND team are preparing our submissions! Looking forward to meeting you all there! #deprescribing

I can’t wait for the 3rd International Conference on Deprescribing and am thrilled to be part of this incredible planning committee! 💊 Stay tuned for more updates!

Agreed! DIAMOND aims to producing robust re-usable tools and resources for deprescribing research by advancing novel methods for harnessing big data. Watch this space: diamond-deprescribing.eu

CP3's @timandersonmd.bsky.social & team discuss the importance of avoiding tunnel vision in recognizing harms in #deprescribing trials. Read more in @agsjournal.bsky.social: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

SR & MA findings: very few (<10%) clinical trials report adverse drug withdrawal event (ADWE) following #deprescribing, and reporting methods are inconsistent. Standardizing reporting is needed to generate more robust evidence on deRXing and ADWEs: agsjournals.onlinelibrary.wiley.com/doi/10.1111/...

Over the past year, CADeN has developed powerful testimonials to raise awareness of med. overload, #deprescribing, and to encourage discussions between patients, caregivers and HCPs. Discover Frances, Micheline, Laurent and Yves' stories here: www.deprescribingnetwork.ca/testimonials

Great 2nd DIAMOND Steering Group meeting today on #WorldHealthDay, bringing together diverse expertise in:  📈 Biostatistics & Data Science  🏥 Health Services Research & GP 💊 Pharmacy & Pharmacoepidemiology  🗣️ Patient & Public Involvement Details here: diamond-deprescribing.eu/team/. #HopefulFutures

Medication needs change across life. On #WorldHealthDay, we launch DIAMOND: Developing Innovative Analytical Methods for research ON Deprescribing. Funded by Wellcome, this research advances methods for studying effects of deprescribing using big data. 🌐 www.diamond-deprescribing.eu #HopefulFutures